Friday, 16 October 2026European Markets

BIGBEN INTERACTIVE And KITRON Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - bigben interactive (big.pa) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
bigben interactive (big.pa) €5.89 4.95% 3.62%
kitron (kit.ol) kr46.75 1.14% 24.07%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. bigben interactive (big.pa)

4.95% forward dividend yield and 3.62% return on equity

bigben interactive designs, produces, and distributes accessories for video game consoles, and smartphones and tablets in france and internationally. it offers audio products; technical support services; accessories, such as controllers, headsets, keyboards, mice, microphones, memory cards, protections, bags, etc. the company also develops, publishes, and distributes video games; and provides technical support services. bigben interactive was incorporated in 1981 and is headquartered in lesquin, france.

earnings per share

as for profitability, bigben interactive has a trailing twelve months eps of €0.33.

pe ratio

bigben interactive has a trailing twelve months price to earnings ratio of 17.85. meaning, the purchaser of the share is investing €17.85 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.62%.

volatility

bigben interactive's last week, last month's, and last quarter's current intraday variation average was a negative 0.51%, a positive 0.73%, and a positive 2.42%.

bigben interactive's highest amplitude of average volatility was 2.55% (last week), 2.38% (last month), and 2.42% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, bigben interactive's stock is considered to be overbought (>=80).

moving average

bigben interactive's worth is above its 50-day moving average of €5.47 and way under its 200-day moving average of €7.82.

yearly top and bottom value

bigben interactive's stock is valued at €5.89 at 07:30 est, way under its 52-week high of €17.44 and way higher than its 52-week low of €4.97.

more news about bigben interactive.

2. kitron (kit.ol)

1.14% forward dividend yield and 24.07% return on equity

kitron asa operates as an electronics manufacturing services company in norway, sweden, rest of europe, the united states, and internationally. it manufactures electronics that are embedded in the customers' products; and box-built electronic products. the company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. the company was incorporated in 1996 and is headquartered in billingstad, norway.

earnings per share

as for profitability, kitron has a trailing twelve months eps of kr2.22.

pe ratio

kitron has a trailing twelve months price to earnings ratio of 21.06. meaning, the purchaser of the share is investing kr21.06 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.07%.

more news about kitron.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com